Disease Markers

Disease Markers / 2010 / Article

Open Access

Volume 28 |Article ID 439048 | https://doi.org/10.3233/DMA-2010-0680

Iris Paola Guzmán-Guzmán, José Francisco Muñoz-Valle, Eugenia Flores-Alfaro, Lorenzo Salgado-Goytia, Aralia Berenice Salgado-Bernabé, Isela Parra-Rojas, "Interleukin-6 Gene Promoter Polymorphisms and Cardiovascular Risk Factors. A family study", Disease Markers, vol. 28, Article ID 439048, 8 pages, 2010. https://doi.org/10.3233/DMA-2010-0680

Interleukin-6 Gene Promoter Polymorphisms and Cardiovascular Risk Factors. A family study

Received12 Feb 2010
Accepted12 Feb 2010


Interleukin-6 (IL-6) is a cytokine involved in inflammatory process, as well as in glucose and lipid metabolism. Several studies of the biological relevance of IL-6 gene polymorphisms have indicated a relationship with cardiovascular disease. The aim of this study was to assess whether the –174 G/C and –572 G/C of IL-6 gene polymorphisms are associated with cardiovascular risk factors in Mexican families. Ninety members of 30 Mexican families, in which an index case (proband) had obesity, were included in the study. We evaluated the body composition by bioelectrical impedance. Peripheral blood samples were collected to determine biochemical and hematological parameters. High sensitivity C- reactive protein levels were measurement for nephelometric analysis. Screening for both polymorphisms studied was performed by PCR-RFLP. In the parents, both polymorphisms were in Hardy-Weinberg's equilibrium. The genotypes –174 GC/CC were associated with T2D (OR = 1.23, IC95% 1.01–1.5) and highest levels of hsCRP (p = 0.02), whereas genotype –572 GG was associated with T2D (OR = 1.24, IC95% 1.04–1.47) with an inflammatory state determined by the increase in the leukocyte count (OR = 1.24, IC95% 1.02–1.51). The genotypes –174 GC/CC and –572 GG may confer susceptibility for the development of subclinical inflammation and type 2 diabetes in Mexican families.

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.